FTDI
ABBV icon

First Trust Direct Indexing’s AbbVie ABBV Stock Holding History

First Trust Direct Indexing’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,538
Closed -$8.99M – 3
2024
Q3 		$8.99M Buy
45,538
+4,601
+11% +$859K 0.48% 27
2024
Q2 		$7.02M Buy
40,937
+6,471
+19% +$1.07M 0.43% 32
2024
Q1 		$6.28M Buy
34,466
+5,915
+21% +$1.02M 0.47% 32
2023
Q4 		$4.42M Buy
28,551
+6,528
+30% +$952K 0.4% 41
2023
Q3 		$3.28M Buy
22,023
+7,039
+47% +$1.03M 0.38% 39
2023
Q2 		$2.02M Sell
14,984
-5,279
-26% -$774K 0.22% 96
2023
Q1 		$3.23M Buy
20,263
+3,347
+20% +$512K 0.38% 41
2022
Q4 		$2.73M Buy
16,916
+2,145
+15% +$329K 0.36% 47
2022
Q3 		$1.98M Buy
14,771
+165
+1% +$23.7K 0.29% 66
2022
Q2 		$2.24M Buy
14,606
+289
+2% +$44.2K 0.31% 61
2022
Q1 		$2.32M Buy
14,317
+2,125
+17% +$309K 0.28% 66
2021
Q4 		$1.65M Buy
12,192
+180
+1% +$21.3K 0.21% 99
2021
Q3 		$1.3M Buy
12,012
+209
+2% +$23.9K 0.18% 121
2021
Q2 		$1.33M Sell
11,803
-232
-2% -$26.1K 0.2% 120
2021
Q1 		$1.3M Buy
12,035
+917
+8% +$98.1K 0.35% 64
2020
Q4 		$1.19M Buy
+11,118
New +$1.07M 0.32% 53

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

First Trust Direct Indexing's ABBV Position: Q4 2024 in Review

First Trust Direct Indexing sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 45,538 shares — an estimated $8.99M sold.

First Trust Direct Indexing first reported a position in ABBV in Q4 2020 and held it in 16 quarters. The position peaked at $8.99M in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • First Trust Direct Indexing reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 45,538 AbbVie shares in Q4 2024, an estimated $8.99M.
  • First Trust Direct Indexing first reported a position in AbbVie in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's AbbVie position peaked at $8.99M in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.